ATLN
ATLANTIC INTERNATIONAL CORP.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.90
+0.00%Price chart
Jun 5Jun 10Jun 15Jun 18Jun 24Jun 29Jul 2Jul 17
Key dataJul 17, 2026
Open$0.73
From 52W high−82.18%
Volume1.45M
Market cap$71.43M
P/E (TTM)—
P/S (TTM)0.1x
Div yield—
Key dataJul 17, 2026
Open
$0.73
From 52W high
−82.18%
Volume
1.45M
Market cap
$71.43M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−6.4x
P/E (TTM)
—
RSI (14)
44.7
MomentumView details →
1D Return
+0.00%
YTD Return
−43.61%
SummaryUpdated Mar 1, 2026
Atlantic International Corp. (NASDAQ:ATLN) is a life sciences instrumentation and research services company founded in 2013 and headquartered in Billerica, Massachusetts. Originally established as SeqLL Inc., the company changed its name to Atlantic International Corp. in June 2024 following a reverse merger acquisition by Lyneer Investments, LLC. The company went public in August 2021 and focuses on developing scientific assets and novel intellectual property across multiple omics fields, particularly in DNA and RNA sequencing technologies for research applications.
Similar companies
Latest newsMore news →
Atlantic International Corp. shares traded down 7.8% on Thursday, with heavy volume.30d agoAtlantic International's Circle8 Group received a one-year contract extension worth $175 million from Rijkswaterstaat, the executive agency of the Dutch Ministry of Infrastructure and Water Management.81d agoAtlantic International Corp's subsidiary Circle8 secured a minimum $52 million government contract award.89d ago